Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-150214
Filing Date
2020-05-22
Accepted
2020-05-22 16:54:02
Documents
1
Effectiveness Date
2020-05-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A d904814ddefa14a.htm DEFA14A 19527
  Complete submission text file 0001193125-20-150214.txt   20546
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 20906668
SIC: 2834 Pharmaceutical Preparations